title: Refractory immune thrombocytopenia after heart transplantation: a case report.
abstract: Chronic immune thrombocytopenia responds to steroids and splenectomy in approximately 80% of the patients. Intravenous immunoglobulin, plasmapheresis, combination chemotherapy, and androgens may help in refractory cases. This report describes the course and management of refractory immune thrombocytopenia after heart transplantation.
authors.affiliation: St. Louis University Health Sciences Center, Mo. 63110, USA.
authors.forename: S C
authors.initials: SC
authors.lastname: Dhar
authors.forename: L W
authors.initials: LW
authors.lastname: Miller
mesh_terms: D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D001792:Blood Platelets / Q000276:immunology; D001853:Bone Marrow / Q000473:pathology; D002908:Chronic Disease; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006330:Heart Defects, Congenital / Q000601:surgery*; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000276:immunology / Q000473:pathology / Q000628:therapy; D010951:Plasma Exchange; D010956:Plasmapheresis; D011183:Postoperative Complications / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D012008:Recurrence; D013156:Splenectomy; D013921:Thrombocytopenia / Q000276:immunology* / Q000473:pathology / Q000628:therapy
chemical_list: D001323:Autoantibodies; D007166:Immunosuppressive Agents